- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06890988
Ending the Epidemic Interventions in the Dental Setting - UH3 (ETE)
Effectiveness of Comprehensive Ending the Epidemic (ETE) Interventions in the Dental Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Routine preventative HIV screening in all health care settings is considered a best practice by the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS) Ending the Epidemic (ETE) Initiative, the New York State Blueprint to End the AIDS Epidemic. Despite this, many patients are not screened for HIV during routine care, including in dental care settings, resulting in missed opportunities for identifying undiagnosed HIV infections and providing education for pre-exposure prophylaxis (PrEP). This study will use information technology to support the delivery of HIV prevention and care best practices in the dental care setting. Dental residents will receive a Best Practice (BPA) alert whenever they have a patient who should be offered HIV screening. This BPA is linked to an order set to simplify ordering HIV tests and reporting results.
A critical knowledge gap for implementing these ETE activities in the dental setting is whether comprehensive ETE efforts could be integrated into existing dental teams consisting of practitioners, dental assistants and hygienists or require augmentation by a dedicated care navigator. To evaluate these two models, the investigators will conduct a crossover clinical trial in 3 urban general dentistry programs (NYP-Columbia, NYP-Cornell, NYP-Queens) randomized to one of 2 arms: (AB) Standard Dental Care Team model followed by crossover to an Enhanced Dental Care Team model with a Care Navigator, or (BA) Enhanced Dental Care Team model with a Care Navigator followed by crossover to a Standard Dental Care Team model.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael Yin, MD, MS
- Phone Number: 212-305-7185
- Email: mty4@cumc.columbia.edu
Study Contact Backup
- Name: Nadia Nguyen, PhD
- Email: nn2442@cumc.columbia.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
-
Contact:
- Michael Yin, MD, MS
- Phone Number: 212-305-7185
- Email: mty4@cumc.columbia.edu
-
Contact:
- Nadia Nguyen, PhD
- Phone Number: 212-304-6212
- Email: nn2442@cumc.columbia.edu
-
New York, New York, United States, 10065
- Not yet recruiting
- Weill Cornell Medical Center / NewYork-Presbyterian Hospital
-
Contact:
- Nadia Nguyen, PhD
- Phone Number: 212-304-6212
- Email: nn2442@cumc.columbia.edu
-
Contact:
- Ariel Blanchard, DMD
- Phone Number: 212-746-5175
- Email: aab9028@med.cornell.edu
-
Queens, New York, United States, 11365
- Not yet recruiting
- NYP-Queens
-
Contact:
- Marsha Rubin, DDS
- Email: Mer2009@med.cornell.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Member of the Dental Team (Provider, Hygienist, Dental Assistant, Care Navigator) at one of the randomized sites with direct patient contact
- Able to provide written informed consent.
Exclusion Criteria:
- Inability to provide written informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Standard Dental Care Team model
Multicomponent HIV Service Package delivered without a Care Navigator
|
Multicomponent HIV Service Package consisting of:
|
|
Experimental: Enhanced Dental Care Team model with a Care Navigator
Multicomponent HIV Service Package delivered with a Care Navigator
|
Multicomponent HIV Service Package consisting of:
The Care Navigator will be added to the dental team as an added resource to:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients that complete point of care HIV testing out of patient encounters receiving clinical decision support (CDS) prompts for HIV testing
Time Frame: 10 months after start of each arm
|
Proportion of patients receiving clinical decision support (CDS) prompts for HIV testing that complete point of care HIV testing over the intervention period under the Enhanced versus Standard Dental Care Models.
|
10 months after start of each arm
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Provider acceptability of multicomponent HIV service package in dental clinics
Time Frame: 5-10 months after start of each arm
|
Provider acceptability of multicomponent HIV service package in dental clinics under the Enhanced versus Standard Dental Care Models.
Acceptability will be assessed using the validated Acceptability of Intervention Measure (AIM).
AIM is a 4-item scale where respondents rate each item using a 5-point ordinal scale that ranges from "completely disagree=1" to "completely agree=5".
The AIM is scored by averaging responses across the 4 items.
A higher average score indicates greater acceptability, which is a better outcome.
|
5-10 months after start of each arm
|
|
Provider feasibility of multicomponent HIV service package in dental clinics
Time Frame: 5-10 months after start of each arm
|
Provider feasibility of multicomponent HIV service package in dental clinics under the Enhanced versus Standard Dental Care Models.
Feasibility will be assessed using the validated Feasibility of Intervention Measure (FIM).
FIM is a 4-item scale where respondents rate each item using a 5-point ordinal scale that ranges from "completely disagree=1" to "completely agree=5".
The FIM is scored by averaging responses across the 4 items.
A higher average score indicates greater acceptability, which is a better outcome.
|
5-10 months after start of each arm
|
|
Proportion of patients receiving CDS prompt for HIV testing that complete subsequent HIV testing outside of the dental clinic
Time Frame: Within 12 months following dental visit
|
Proportion of patients receiving CDS prompt for HIV testing that complete subsequent HIV testing outside of the dental clinic under the Enhanced versus Standard Dental Care Models.
|
Within 12 months following dental visit
|
|
Proportion of patients receiving CDS prompt for HIV testing with subsequent appointment at an HIV prevention clinic
Time Frame: Within 12 months following dental visit
|
Proportion of patients receiving CDS prompt for HIV testing with subsequent appointment at an HIV prevention clinic under the Enhanced versus Standard Dental Care Models.
|
Within 12 months following dental visit
|
|
Proportion of patients receiving CDS prompt for HIV testing subsequently prescribed pre-exposure prophylaxis (PrEP) medication
Time Frame: Within 12 months following dental visit
|
Proportion of patients receiving CDS prompt for HIV testing subsequently prescribed pre-exposure prophylaxis (PrEP) medication under the Enhanced versus Standard Dental Care Models.
|
Within 12 months following dental visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AAAT8854 - UH3
- 4UH3DE031258 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV-1-infection
-
Federal University of São PauloGilead SciencesCompleted
-
Fundación HuéspedViiV HealthcareNot yet recruitingHIV-1-infectionArgentina, Brazil
-
Fundación HuéspedMSD Pharmaceuticals LLC; Fundacion IDEAANot yet recruiting
-
Henan Genuine Biotech Co., Ltd.Recruiting
-
University of North Carolina, Chapel HillNot yet recruiting
-
Craig Cohen, MD, MPHNational Institute of Allergy and Infectious Diseases (NIAID); Duke University and other collaboratorsRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
BioNTech SERecruitingHIV -1 InfectionGermany, United States
-
TaiMed Biologics Inc.Active, not recruitingHIV -1 InfectionUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA)Not yet recruitingHIV -1 Infection | Methamphetamine UseUnited States
Clinical Trials on Multicomponent HIV Service Package
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse, Intravenous | Human Immunodeficiency VirusUnited States, Kazakhstan
-
Xuanwu Hospital, BeijingNot yet recruitingCoronary Artery Disease | Stroke | Hypertension | Diabetes Mellitus | Arthritis | Cognitive Impairment | Dyslipidemia | Chronic Kidney Disease | Multimorbidity | Chronic Liver Diseases | Depression - Major Depressive Disorder
-
Centre Leon BerardConseil general de l'IsereCompleted
-
ANRS, Emerging Infectious DiseasesUniversité Montpellier; Expertise France; ARCAD-SIDA MALI; Coalition Internationale... and other collaboratorsCompletedHIV/AIDSMali, Burkina Faso, Togo, Côte d’Ivoire
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)Completed
-
London School of Hygiene and Tropical MedicineBiomedical Research and Training InstituteCompleted
-
University of California, Los AngelesCenters for Disease Control and Prevention, ChinaCompletedPatient Satisfaction | HIV-related Stigma | Provider-patient InteractionUnited States
-
Health Poverty ActionGavi, The Vaccine Alliance; University of Health Sciences LaosRecruitingHealthy | Attitude | Adolescents | Knowledge | HPV Vaccines | Integrated, Community-Health Systems | Sexual and Reproductive Health | Health WorkersLao People's Democratic Republic
-
Columbia UniversityCenters for Disease Control and Prevention; Ministry of Health, Lesotho; National...Completed